BamSEC and AlphaSense Join Forces
Learn More

Xilio Therapeutics Inc. – Transcripts

NASDAQ: XLO    
Share price (6/29/26): $9.27    
Market cap (6/29/26): $61.0 million
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2025
Other Revised 11/11/25 Xilio Therapeutics, Inc. - Special Call 11/10/25
Other Revised 02/12/25 Xilio Therapeutics, Inc. - Special Call 02/12/25
Other Revised 02/21/25 Xilio Therapeutics, Inc. - Special Call 01/22/25
CY 2024
Other Revised 11/08/24 Xilio Therapeutics, Inc. - Special Call 11/07/24
Other Revised 09/04/24 Xilio Therapeutics, Inc. Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-04-2024 07:00 AM 09/04/24
Other Revised 05/31/24 Xilio Therapeutics, Inc. - Special Call 03/28/24
CY 2023
Other Revised 11/06/23 Xilio Therapeutics, Inc. - Special Call 11/06/23
Other Revised 09/11/23 Xilio Therapeutics, Inc. Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-11-2023 02:55 PM 09/11/23
Other Revised 08/17/23 Xilio Therapeutics, Inc. - Special Call 08/17/23
Other Revised 02/23/23 Xilio Therapeutics, Inc. Presents at Citi's 2023 Virtual Oncology Leadership Summit, Feb-23-2023 09:00 AM 02/23/23
CY 2022
Other Revised 12/01/22 Xilio Therapeutics, Inc. - Special Call 12/01/22
Other Revised 09/13/22 Xilio Therapeutics, Inc. Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-13-2022 02:55 PM 09/13/22